Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fujifilm Gains Handheld Ultrasound Devices With SonoSite Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Imaging device maker Fujifilm buys SonoSite for $995 million, gaining handheld ultrasound devices including Edge, M-Turbo, MicroMaxx and NanoMaxx systems for applications including critical care, musculoskeletal, ob/gyn, vascular, cardiac and superficial imaging.

You may also be interested in...

Device and Diagnostics Dealmaking Quarterly Statistics, Q4 2011

Medical device companies raised $800 million in the fourth quarter of 2011, and venture capital represented half of that amount. Just over $4 billion was spent to acquire medical device companies, down 50% from Q3’s $8 billion. In vitro diagnostics/research financings were well above the previous quarter, raking in a total of $269 million, with late-stage rounds again bringing in most of the Q4 money. Only five M&A deals were completed, totalling $915 million – way down from Q3’s $2.8 billion for the same number of deals.

New Products In Brief

Fujifilm’s Aspire HD gains FDA clearance

FujiFilm Medical Seeks Familiar Approach To 3D Mammography, With Glasses

FujiFilm Medical Systems is developing what could be a shortcut to viewing three-dimensional digital mammography images. Key to the approach: 3D glasses.


Related Companies

Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts